{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:36:08Z","timestamp":1787668568339,"version":"build-2736575974"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02139-7","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T06:02:34Z","timestamp":1725343354000},"page":"1078-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Neuroprotective Effects of Agmatine on Parkinson\u2019s Disease: Focus on Oxidative Stress, Inflammation and Molecular Mechanisms"],"prefix":"10.1007","volume":"48","author":[{"given":"Mohammad Yasin","family":"Zamanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Nazifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine G.","family":"Khachatryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehraveh Sadeghi","family":"Ivraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya V.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beneen","family":"Husseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D. V.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliya","family":"Petkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikta","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"7","key":"2139_CR1","first-page":"596","volume":"21","author":"S Kumar","year":"2022","unstructured":"Kumar, S., L. Goyal, and S. Singh. 2022. Tremor and rigidity in patients with Parkinson\u2019s disease: Emphasis on epidemiology, pathophysiology and contributing factors. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 21 (7): 596\u2013609.","journal-title":"CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"18","key":"2139_CR2","doi-asserted-by":"publisher","first-page":"10808","DOI":"10.3390\/ijms231810808","volume":"23","author":"M Huang","year":"2022","unstructured":"Huang, M., et al. 2022. Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of parkinson\u2019s disease. International journal of molecular sciences 23 (18): 10808.","journal-title":"International journal of molecular sciences"},{"issue":"11","key":"2139_CR3","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","volume":"42","author":"S Mani","year":"2021","unstructured":"Mani, S., et al. 2021. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurological Sciences 42 (11): 4459\u20134469.","journal-title":"Neurological Sciences"},{"issue":"1","key":"2139_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson, M.E., et al. 2019. Triggers, facilitators, and aggravators: Redefining Parkinson\u2019s disease pathogenesis. Trends in Neurosciences 42 (1): 4\u201313.","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"2139_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1073858421991066","volume":"28","author":"T Wang","year":"2022","unstructured":"Wang, T., et al. 2022. Neuroinflammation in Parkinson\u2019s disease: Triggers, mechanisms, and immunotherapies. The Neuroscientist 28 (4): 364\u2013381.","journal-title":"The Neuroscientist"},{"issue":"4","key":"2139_CR6","first-page":"1817","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo, J.D., et al. 2018. Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease. International Journal of Molecular Medicine 41 (4): 1817\u20131825.","journal-title":"International Journal of Molecular Medicine"},{"key":"2139_CR7","doi-asserted-by":"publisher","first-page":"121049","DOI":"10.1016\/j.lfs.2022.121049","volume":"311","author":"YO Azar","year":"2022","unstructured":"Azar, Y.O., et al. 2022. Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1\/RAGE\/TLR4\/MYD88\/NF-\u03baB signaling cascade in rotenone lesioned rats. Life Sciences 311: 121049.","journal-title":"Life Sciences"},{"issue":"2","key":"2139_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5115\/acb.21.089","volume":"54","author":"R Kosonen","year":"2021","unstructured":"Kosonen, R., et al. 2021. Role of agmatine in the application of neural progenitor cell in central nervous system diseases: Therapeutic potentials and effects. Anatomy & Cell Biology 54 (2): 143.","journal-title":"Anatomy & Cell Biology"},{"issue":"1","key":"2139_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2958.2010.07083.x","volume":"76","author":"BJ Williams","year":"2010","unstructured":"Williams, B.J., et al. 2010. Discovery of an operon that participates in agmatine metabolism and regulates biofilm formation in Pseudomonas aeruginosa. Molecular Microbiology 76 (1): 104\u2013119.","journal-title":"Molecular Microbiology"},{"issue":"17\u201318","key":"2139_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz, J.E., et al. 2013. Agmatine: Clinical applications after 100 years in translation. Drug Discovery Today 18 (17\u201318): 880\u2013893.","journal-title":"Drug Discovery Today"},{"issue":"4","key":"2139_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nchembio.323","volume":"6","author":"Y Ikeuchi","year":"2010","unstructured":"Ikeuchi, Y., et al. 2010. Agmatine-conjugated cytidine in a tRNA anticodon is essential for AUA decoding in archaea. Nature Chemical Biology 6 (4): 277\u2013282.","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"2139_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/bj3160247","volume":"316","author":"E Galea","year":"1996","unstructured":"Galea, E., et al. 1996. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochemical Journal 316 (1): 247\u2013249.","journal-title":"Biochemical Journal"},{"issue":"1","key":"2139_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","volume":"36","author":"TI Uzbay","year":"2012","unstructured":"Uzbay, T.I. 2012. The pharmacological importance of agmatine in the brain. Neuroscience & Biobehavioral Reviews 36 (1): 502\u2013519.","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"15","key":"2139_CR14","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1042\/BCJ20170007","volume":"474","author":"G Laube","year":"2017","unstructured":"Laube, G., and H.-G. Bernstein. 2017. Agmatine: Multifunctional arginine metabolite and magic bullet in clinical neuroscience? Biochemical Journal 474 (15): 2619\u20132640.","journal-title":"Biochemical Journal"},{"issue":"1","key":"2139_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1304.001","volume":"1009","author":"A Halaris","year":"2003","unstructured":"Halaris, A., and J.E. Piletz. 2003. Relevance of imidazoline receptors and agmatine to psychiatry: A decade of progress. Annals of the new York Academy of Sciences 1009 (1): 1\u201320.","journal-title":"Annals of the new York Academy of Sciences"},{"key":"2139_CR16","doi-asserted-by":"crossref","unstructured":"Saha, P., et al. 2023. Neuroprotection by agmatine: Possible involvement of the gut microbiome? Ageing Research Reviews 91:102056.","DOI":"10.1016\/j.arr.2023.102056"},{"key":"2139_CR17","doi-asserted-by":"crossref","unstructured":"Rafi, Hira, Hamna Rafiq, and Muhammad Farhan. 2024. Pharmacological profile of agmatine: An in-depth overview. Neuropeptides 105:102429.","DOI":"10.1016\/j.npep.2024.102429"},{"issue":"15","key":"2139_CR18","doi-asserted-by":"publisher","first-page":"e00722","DOI":"10.1128\/AEM.00722-18","volume":"84","author":"N Akasaka","year":"2018","unstructured":"Akasaka, N., et al. 2018. Agmatine production by Aspergillus oryzae is elevated by low pH during solid-state cultivation. Applied and Environmental Microbiology 84 (15): e00722-e818.","journal-title":"Applied and Environmental Microbiology"},{"key":"2139_CR19","doi-asserted-by":"crossref","unstructured":"\u00d6zdestan, O.Z.l. and A. Uren. 2010. Biogenic amine content of shalgam (salgam): a traditional lactic acid fermented Turkish beverage. Journal of agricultural and food chemistry 58(4): 2602\u20132608.","DOI":"10.1021\/jf903775z"},{"issue":"9","key":"2139_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0753-3322(02)00273-1","volume":"56","author":"N Flynn","year":"2002","unstructured":"Flynn, N., et al. 2002. The metabolic basis of arginine nutrition and pharmacotherapy. Biomedicine & Pharmacotherapy 56 (9): 427\u2013438.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"2139_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pharmthera.2011.12.005","volume":"133","author":"GJ Molderings","year":"2012","unstructured":"Molderings, G.J., and B. Haenisch. 2012. Agmatine (decarboxylated L-arginine): Physiological role and therapeutic potential. Pharmacology & Therapeutics 133 (3): 351\u2013365.","journal-title":"Pharmacology & Therapeutics"},{"issue":"23","key":"2139_CR22","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1021\/acs.jafc.0c02605","volume":"68","author":"W Wang","year":"2020","unstructured":"Wang, W., H.D. Snooks, and S. Sang. 2020. The chemistry and health benefits of dietary phenolamides. Journal of Agricultural and Food Chemistry 68 (23): 6248\u20136267.","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"4","key":"2139_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1472-765X.2011.03120.x","volume":"53","author":"M Arena","year":"2011","unstructured":"Arena, M., et al. 2011. Expression of Lactobacillus brevis IOEB 9809 tyrosine decarboxylase and agmatine deiminase genes in wine correlates with substrate availability. Letters in Applied Microbiology 53 (4): 395\u2013402.","journal-title":"Letters in Applied Microbiology"},{"issue":"5","key":"2139_CR24","doi-asserted-by":"publisher","first-page":"e00294","DOI":"10.1128\/aem.00294-24","volume":"90","author":"Y Murakami","year":"2024","unstructured":"Murakami, Y., et al. 2024. Identification and enzymatic properties of arginine decarboxylase from Aspergillus oryzae. Applied and Environmental Microbiology 90 (5): e00294-e324.","journal-title":"Applied and Environmental Microbiology"},{"issue":"11","key":"2139_CR25","doi-asserted-by":"publisher","first-page":"e14875","DOI":"10.1111\/jfpp.14875","volume":"44","author":"J Wang","year":"2020","unstructured":"Wang, J., et al. 2020. Effects of NaCl on gene expression of agmatine deiminase pathway genes of putrescine in Lactobacillus delbrueckii and Escherichia coli. Journal of Food Processing and Preservation 44 (11): e14875.","journal-title":"Journal of Food Processing and Preservation"},{"issue":"20","key":"2139_CR26","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1128\/JB.00772-07","volume":"189","author":"TN Giles","year":"2007","unstructured":"Giles, T.N., and D.E. Graham. 2007. Characterization of an acid-dependent arginine decarboxylase enzyme from Chlamydophila pneumoniae. Journal of bacteriology 189 (20): 7376\u20137383.","journal-title":"Journal of bacteriology"},{"issue":"2","key":"2139_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1271\/bbb.70550","volume":"72","author":"S Liao","year":"2008","unstructured":"Liao, S., et al. 2008. Occurrence of agmatine pathway for putrescine synthesis in Selenomonas ruminatium. Bioscience, biotechnology, and biochemistry 72 (2): 445\u2013455.","journal-title":"Bioscience, biotechnology, and biochemistry"},{"key":"2139_CR28","doi-asserted-by":"publisher","first-page":"112692","DOI":"10.1016\/j.bbr.2020.112692","volume":"392","author":"SS Bilge","year":"2020","unstructured":"Bilge, S.S., et al. 2020. Neuroprotective action of agmatine in rotenone-induced model of Parkinson\u2019s disease: Role of BDNF\/cREB and ERK pathway. Behavioural Brain Research 392: 112692.","journal-title":"Behavioural Brain Research"},{"key":"2139_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00702-007-0690-z","volume":"114","author":"M \u0160ebela","year":"2007","unstructured":"\u0160ebela, M., M. Tylichov\u00e1, and P. Pe\u010d. 2007. Inhibition of diamine oxidases and polyamine oxidases by diamine-based compounds. Journal of Neural Transmission 114: 793\u2013798.","journal-title":"Journal of Neural Transmission"},{"key":"2139_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuro.2024.03.002","volume":"102","author":"R Katariya","year":"2024","unstructured":"Katariya, R., et al. 2024. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington\u2019s disease in rats. Neurotoxicology 102: 12\u201328.","journal-title":"Neurotoxicology"},{"key":"2139_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.procbio.2020.09.012","volume":"99","author":"B Li","year":"2020","unstructured":"Li, B., and S. Lu. 2020. The importance of amine-degrading enzymes on the biogenic amine degradation in fermented foods: A review. Process Biochemistry 99: 331\u2013339.","journal-title":"Process Biochemistry"},{"issue":"1","key":"2139_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/catal13010048","volume":"13","author":"Z Tan","year":"2022","unstructured":"Tan, Z., et al. 2022. Advances in the clinical application of histamine and diamine oxidase (DAO) activity: A review. Catalysts 13 (1): 48.","journal-title":"Catalysts"},{"issue":"9","key":"2139_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/0006-2952(76)90496-2","volume":"25","author":"RE Shaff","year":"1976","unstructured":"Shaff, R.E., and M.A. Beaven. 1976. Turnover and synthesis of diamine oxidase (DAO) in rat tissues. Studies with heparin and cycloheximide. Biochemical Pharmacology. 25 (9): 1057\u20131062.","journal-title":"Biochemical Pharmacology."},{"issue":"1","key":"2139_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/life13010240","volume":"13","author":"M Mayo-Y\u00e1\u00f1ez","year":"2023","unstructured":"Mayo-Y\u00e1\u00f1ez, M., et al. 2023. Diamine Oxidase Activity Deficit and Idiopathic Rhinitis: A New Subgroup of Non-Allergic Rhinitis? Life 13 (1): 240.","journal-title":"Life"},{"key":"2139_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.metabol.2017.11.005","volume":"81","author":"J Ben\u00edtez","year":"2018","unstructured":"Ben\u00edtez, J., et al. 2018. Metabolic strategies for the degradation of the neuromodulator agmatine in mammals. Metabolism 81: 35\u201344.","journal-title":"Metabolism"},{"issue":"5","key":"2139_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.phrs.2003.10.008","volume":"49","author":"SA Raghavan","year":"2004","unstructured":"Raghavan, S.A., and M. Dikshit. 2004. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacological Research 49 (5): 397\u2013414.","journal-title":"Pharmacological Research"},{"key":"2139_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11064-018-02712-1","volume":"44","author":"S Barua","year":"2019","unstructured":"Barua, S., et al. 2019. Therapeutic effect of agmatine on neurological disease: Focus on ion channels and receptors. Neurochemical Research 44: 735\u2013750.","journal-title":"Neurochemical Research"},{"issue":"13\u201314","key":"2139_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.lfs.2011.07.003","volume":"89","author":"HW Song","year":"2011","unstructured":"Song, H.W., et al. 2011. Agmatine enhances neurogenesis by increasing ERK1\/2 expression, and suppresses astrogenesis by decreasing BMP 2, 4 and SMAD 1, 5, 8 expression in subventricular zone neural stem cells. Life Sciences 89 (13\u201314): 439\u2013449.","journal-title":"Life Sciences"},{"issue":"19","key":"2139_CR39","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.97.19.10584","volume":"97","author":"CA Fairbanks","year":"2000","unstructured":"Fairbanks, C.A., et al. 2000. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proceedings of the National Academy of Sciences 97 (19): 10584\u201310589.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2139_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.phrs.2016.03.023","volume":"112","author":"GP Guerra","year":"2016","unstructured":"Guerra, G.P., M.A. Rubin, and C.F. Mello. 2016. Modulation of learning and memory by natural polyamines. Pharmacological Research 112: 99\u2013118.","journal-title":"Pharmacological Research"},{"issue":"8","key":"2139_CR41","first-page":"889","volume":"46","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., et al. 2021. Agmatine and glycolipid metabolism. Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Medical Sciences. 46 (8): 889\u2013893.","journal-title":"Medical Sciences."},{"key":"2139_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainresbull.2020.04.013","volume":"160","author":"N Kotagale","year":"2020","unstructured":"Kotagale, N., et al. 2020. Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer\u2019s disease. Brain Research Bulletin 160: 56\u201364.","journal-title":"Brain Research Bulletin"},{"key":"2139_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuro.2019.05.001","volume":"73","author":"NR Kotagale","year":"2019","unstructured":"Kotagale, N.R., B.G. Taksande, and N.N. Inamdar. 2019. Neuroprotective offerings by agmatine. Neurotoxicology 73: 228\u2013245.","journal-title":"Neurotoxicology"},{"key":"2139_CR44","doi-asserted-by":"publisher","first-page":"102269","DOI":"10.1016\/j.arr.2024.102269","volume":"96","author":"RA Katariya","year":"2024","unstructured":"Katariya, R.A., et al. 2024. Agmatine as a Novel Intervention for Alzheimer\u2019s Disease: Pathological Insights and Cognitive Benefits. Ageing Research Reviews 96: 102269.","journal-title":"Ageing Research Reviews"},{"key":"2139_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","volume":"353","author":"ACG de Souza","year":"2018","unstructured":"de Souza, A.C.G., et al. 2018. Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice. Behavioural Brain Research 353: 51\u201356.","journal-title":"Behavioural Brain Research"},{"issue":"6","key":"2139_CR46","doi-asserted-by":"publisher","first-page":"C1411","DOI":"10.1152\/ajpcell.00529.2008","volume":"296","author":"MA Arndt","year":"2009","unstructured":"Arndt, M.A., et al. 2009. The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis. American Journal of Physiology-Cell Physiology 296 (6): C1411\u2013C1419.","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"9","key":"2139_CR47","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2174\/1570159X15666170808120633","volume":"16","author":"W Xu","year":"2018","unstructured":"Xu, W., et al. 2018. Neuroprotective role of agmatine in neurological diseases. Current Neuropharmacology 16 (9): 1296\u20131305.","journal-title":"Current Neuropharmacology"},{"issue":"3","key":"2139_CR48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5115\/acb.2010.43.3.230","volume":"43","author":"CH Mun","year":"2010","unstructured":"Mun, C.H., et al. 2010. Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain. Anatomy & Cell Biology 43 (3): 230.","journal-title":"Anatomy & Cell Biology"},{"key":"2139_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.brainres.2017.03.004","volume":"1663","author":"NB Gawali","year":"2017","unstructured":"Gawali, N.B., et al. 2017. Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway. Brain Research 1663: 66\u201377.","journal-title":"Brain Research"},{"issue":"17","key":"2139_CR50","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1523\/JNEUROSCI.4720-07.2008","volume":"28","author":"S Schuster","year":"2008","unstructured":"Schuster, S., et al. 2008. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson\u2019s disease. Journal of Neuroscience 28 (17): 4311\u20134316.","journal-title":"Journal of Neuroscience"},{"key":"2139_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00726-019-02759-6","volume":"52","author":"N Ferlazzo","year":"2020","unstructured":"Ferlazzo, N., et al. 2020. Up-regulation of HIF-1\u03b1 is associated with neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells. Amino Acids 52: 171\u2013179.","journal-title":"Amino Acids"},{"issue":"3","key":"2139_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/ANA.0000000000000195","volume":"28","author":"JM Kim","year":"2016","unstructured":"Kim, J.M., et al. 2016. The anti-inflammatory effects of agmatine on transient focal cerebral ischemia in diabetic rats. Journal of Neurosurgical Anesthesiology 28 (3): 203\u2013213.","journal-title":"Journal of Neurosurgical Anesthesiology"},{"key":"2139_CR53","doi-asserted-by":"publisher","unstructured":"Sezer, A., et al. 2014. Neuroprotective effects of agmatine \u0131n experimental peripheral nerve \u0131njury \u0131n rats: a prospective randomized and placebo-controlled trial. https:\/\/doi.org\/10.5137\/1019-5149.JTN.7324-12.1","DOI":"10.5137\/1019-5149.JTN.7324-12.1"},{"issue":"2","key":"2139_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36922\/itps.361","volume":"5","author":"MD Dhokne","year":"2023","unstructured":"Dhokne, M.D., et al. 2023. Agmatine as a Novel Treatment Option for Neuropathies: Experimental Evidences. INNOSC Theranostics and Pharmacological Sciences 5 (2): 1\u201310.","journal-title":"INNOSC Theranostics and Pharmacological Sciences"},{"issue":"2","key":"2139_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/bne0000499","volume":"136","author":"AP Fran\u00e7a","year":"2022","unstructured":"Fran\u00e7a, A.P., et al. 2022. Agmatine improves olfactory and cognitive deficits in Spontaneously Hypertensive Rats (SHR): An animal model of Attention Deficit Hyperactivity Disorder (ADHD). Behavioral Neuroscience 136 (2): 139.","journal-title":"Behavioral Neuroscience"},{"issue":"8","key":"2139_CR56","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","volume":"12","author":"T-W Chou","year":"2021","unstructured":"Chou, T.-W., et al. 2021. Fibrillar \u03b1-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-\u03baB. Cell Death & Disease 12 (8): 756.","journal-title":"Cell Death & Disease"},{"issue":"13","key":"2139_CR57","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jcmm.17784","volume":"27","author":"M Alrouji","year":"2023","unstructured":"Alrouji, M., et al. 2023. NF-\u03baB\/NLRP3 inflammasome axis and risk of Parkinson\u2019s disease in Type 2 diabetes mellitus: A narrative review and new perspective. Journal of Cellular and Molecular Medicine 27 (13): 1775\u20131789.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"12","key":"2139_CR58","doi-asserted-by":"publisher","first-page":"30223","DOI":"10.3390\/ijms161226227","volume":"16","author":"Y Chen","year":"2015","unstructured":"Chen, Y., et al. 2015. Applications of micro-fourier transform infrared spectroscopy (FTIR) in the geological sciences\u2014a review. International Journal of Molecular Sciences 16 (12): 30223\u201330250.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2139_CR59","doi-asserted-by":"publisher","first-page":"17625","DOI":"10.1038\/srep17625","volume":"5","author":"K Araki","year":"2015","unstructured":"Araki, K., et al. 2015. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson\u2019s disease patients. Scientific Reports 5 (1): 17625.","journal-title":"Scientific Reports"},{"issue":"6","key":"2139_CR60","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1039\/D3CP04527G","volume":"26","author":"MNS Karabo\u011fa","year":"2024","unstructured":"Karabo\u011fa, M.N.S., et al. 2024. An innovative method for the detection of alpha synuclein, a potential biomarker of Parkinson\u2019s disease: Quartz tuning fork-based mass sensitive immunosensor design. Physical Chemistry Chemical Physics 26 (6): 5106\u20135114.","journal-title":"Physical Chemistry Chemical Physics"},{"issue":"8","key":"2139_CR61","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani, S., et al. 2023. Mitochondrial dysfunction and Parkinson\u2019s disease: Pathogenesis and therapeutic strategies. Neurochemical Research 48 (8): 2285\u20132308.","journal-title":"Neurochemical Research"},{"issue":"12","key":"2139_CR62","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.1038\/s41380-021-01284-x","volume":"26","author":"EH Ahn","year":"2021","unstructured":"Ahn, E.H., et al. 2021. Mitochondrial dysfunction triggers the pathogenesis of Parkinson\u2019s disease in neuronal C\/EBP\u03b2 transgenic mice. Molecular Psychiatry 26 (12): 7838\u20137850.","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"2139_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.31083\/j.fbl2901036","volume":"29","author":"A Blagov","year":"2024","unstructured":"Blagov, A., et al. 2024. Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson\u2019s Disease. Frontiers in Bioscience-Landmark 29 (1): 36.","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"3","key":"2139_CR64","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1526-4637.2010.00808.x","volume":"11","author":"O Keynan","year":"2010","unstructured":"Keynan, O., et al. 2010. Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial. Pain Medicine 11 (3): 356\u2013368.","journal-title":"Pain Medicine"},{"issue":"11","key":"2139_CR65","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1089\/jmf.2014.0026","volume":"17","author":"GM Gilad","year":"2014","unstructured":"Gilad, G.M., and V.H. Gilad. 2014. Long-term (5 years), high daily dosage of dietary agmatine\u2014evidence of safety: A case report. Journal of medicinal food 17 (11): 1256\u20131259.","journal-title":"Journal of medicinal food"},{"issue":"1","key":"2139_CR66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.07085.x","volume":"116","author":"S Condello","year":"2011","unstructured":"Condello, S., et al. 2011. Agmatine effects on mitochondrial membrane potential andNF-\u03baB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. Journal of Neurochemistry 116 (1): 67\u201375.","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"2139_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/mds.870090202","volume":"9","author":"A Schapira","year":"1994","unstructured":"Schapira, A. 1994. Evidence for mitochondrial dysfunction in Parkinson\u2019s disease\u2014a critical appraisal. Movement Disorders 9 (2): 125\u2013138.","journal-title":"Movement Disorders"},{"issue":"9","key":"2139_CR68","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1021\/ja00269a065","volume":"108","author":"L Sayre","year":"1986","unstructured":"Sayre, L., et al. 1986. Mechanism of induction of Parkinson\u2019s disease by 1 methyl-4-phenyl-1,2, 3, 6-tetrahydropyridine (MPTP). Chemical and electrochemical characterization of a geminal-dimethyl-blocked analog of a postulated toxic metabolite. Journal of the American Chemical Society 108 (9): 2464\u20132466.","journal-title":"Journal of the American Chemical Society"},{"issue":"2","key":"2139_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","volume":"235","author":"FC Matheus","year":"2012","unstructured":"Matheus, F.C., et al. 2012. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Behavioural brain research 235 (2): 263\u2013272.","journal-title":"Behavioural brain research"},{"key":"2139_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2014.07.014","volume":"579","author":"Y Feng","year":"2014","unstructured":"Feng, Y., et al. 2014. Neuroprotection by Orexin-A via HIF-1\u03b1 induction in a cellular model of Parkinson\u2019s disease. Neuroscience letters 579: 35\u201340.","journal-title":"Neuroscience letters"},{"issue":"3","key":"2139_CR71","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1139\/bcb-2019-0117","volume":"98","author":"M Mehrabani","year":"2020","unstructured":"Mehrabani, M., et al. 2020. Protective effect of hydralazine on a cellular model of Parkinson\u2019s disease: A possible role of hypoxia-inducible factor (HIF)-1\u03b1. Biochemistry and Cell Biology 98 (3): 405\u2013414.","journal-title":"Biochemistry and Cell Biology"},{"key":"2139_CR72","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11064-005-6865-9","volume":"30","author":"GM Gilad","year":"2005","unstructured":"Gilad, G.M., et al. 2005. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity. Neurochemical Research 30: 713\u2013719.","journal-title":"Neurochemical Research"},{"key":"2139_CR73","doi-asserted-by":"publisher","first-page":"986668","DOI":"10.3389\/fphar.2022.986668","volume":"13","author":"SK Pandey","year":"2022","unstructured":"Pandey, S.K., and R.K. Singh. 2022. Recent developments in nucleic acid-based therapies for Parkinson\u2019s disease: Current status, clinical potential, and future strategies. Frontiers in Pharmacology 13: 986668.","journal-title":"Frontiers in Pharmacology"},{"issue":"22","key":"2139_CR74","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1523\/JNEUROSCI.1419-21.2022","volume":"42","author":"X Xu","year":"2022","unstructured":"Xu, X., et al. 2022. CREB inactivation by HDAC1\/PP1\u03b3 contributes to dopaminergic neurodegeneration in Parkinson\u2019s disease. Journal of Neuroscience 42 (22): 4594\u20134604.","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"2139_CR75","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz, E., et al. 2020. BDNF as a promising therapeutic agent in Parkinson\u2019s disease. International journal of molecular sciences 21 (3): 1170.","journal-title":"International journal of molecular sciences"},{"key":"2139_CR76","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11064-020-03058-3","volume":"45","author":"A Singh","year":"2020","unstructured":"Singh, A., et al. 2020. Promising polyphenols in Parkinson\u2019s disease therapeutics. Neurochemical Research 45: 1731\u20131745.","journal-title":"Neurochemical Research"},{"key":"2139_CR77","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1007\/s11064-008-9697-6","volume":"33","author":"K Aquilano","year":"2008","unstructured":"Aquilano, K., et al. 2008. Role of nitric oxide synthases in Parkinson\u2019s disease: A review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochemical Research 33: 2416\u20132426.","journal-title":"Neurochemical Research"},{"issue":"7","key":"2139_CR78","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbadis.2014.02.010","volume":"1842","author":"A Ferretta","year":"2014","unstructured":"Ferretta, A., et al. 2014. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson\u2019s disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1842 (7): 902\u2013915.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease."},{"issue":"6","key":"2139_CR79","first-page":"437","volume":"66","author":"W Fan","year":"2023","unstructured":"Fan, W., and J. Zhou. 2023. Icariside II suppresses ferroptosis to protect against MPP+-Induced Parkinson\u2019s disease through Keap1\/Nrf2\/GPX4 signaling. Journal of Physiological Investigation 66 (6): 437\u2013445.","journal-title":"Journal of Physiological Investigation"},{"issue":"11","key":"2139_CR80","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/biomedicines10112929","volume":"10","author":"IU Rehman","year":"2022","unstructured":"Rehman, I.U., et al. 2022. Neuroprotective effects of nicotinamide against mptp-induced parkinson\u2019s disease in mice: Impact on oxidative stress, neuroinflammation, nrf2\/ho-1 and tlr4 signaling pathways. Biomedicines 10 (11): 2929.","journal-title":"Biomedicines"},{"key":"2139_CR81","doi-asserted-by":"publisher","first-page":"173412","DOI":"10.1016\/j.ejphar.2020.173412","volume":"886","author":"MS Uddin","year":"2020","unstructured":"Uddin, M.S., et al. 2020. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration. European Journal of Pharmacology 886: 173412.","journal-title":"European Journal of Pharmacology"},{"issue":"13","key":"2139_CR82","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/nu16132041","volume":"16","author":"E Riegelman","year":"2024","unstructured":"Riegelman, E., et al. 2024. Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on \u03b1-Synuclein in Parkinson\u2019s Disease. Nutrients 16 (13): 2041.","journal-title":"Nutrients"},{"issue":"6","key":"2139_CR83","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","volume":"50","author":"MY Zamanian","year":"2023","unstructured":"Zamanian, M.Y., et al. 2023. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments. Molecular Biology Reports 50 (6): 5455\u20135464.","journal-title":"Molecular Biology Reports"},{"issue":"5","key":"2139_CR84","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/WNR.0000000000001884","volume":"34","author":"J Zhang","year":"2023","unstructured":"Zhang, J., et al. 2023. Paeoniflorin protects 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease mice by inhibiting oxidative stress and neuronal apoptosis through activating the Nrf2\/HO-1 signaling pathway. Neuroreport 34 (5): 255\u2013266.","journal-title":"Neuroreport"},{"issue":"s1","key":"2139_CR85","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.3233\/JAD-220793","volume":"94","author":"SM Shirgadwar","year":"2023","unstructured":"Shirgadwar, S.M., et al. 2023. Neuroprotective effect of Phloretin in rotenone-induced mice model of Parkinson\u2019s disease: modulating mTOR-NRF2-P62 mediated autophagy-oxidative stress crosstalk. Journal of Alzheimer's Disease 94 (s1): S109\u2013S124.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"2139_CR86","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/med.21714","volume":"41","author":"C Bento-Pereira","year":"2021","unstructured":"Bento-Pereira, C., and A.T. Dinkova-Kostova. 2021. Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson\u2019s disease. Medicinal Research Reviews 41 (2): 785\u2013802.","journal-title":"Medicinal Research Reviews"},{"key":"2139_CR87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"SS Singh","year":"2020","unstructured":"Singh, S.S., et al. 2020. NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotoxicity Research 37: 491\u2013507.","journal-title":"Neurotoxicity Research"},{"issue":"6","key":"2139_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2023.13122","volume":"28","author":"T Li","year":"2023","unstructured":"Li, T., et al. 2023. Neferine exerts anti-inflammatory activity in BV-2 microglial cells and protects mice with MPTP-induced Parkinson\u2019s disease by inhibiting NF-\u03baB activation. Molecular Medicine Reports 28 (6): 1\u20139.","journal-title":"Molecular Medicine Reports"},{"issue":"11","key":"2139_CR89","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/1440-1681.13709","volume":"49","author":"L Guo","year":"2022","unstructured":"Guo, L., et al. 2022. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt\/ERK\/JNK\/NF-\u03baB signalling pathways in a model of Parkinson\u2019s disease. Clinical and Experimental Pharmacology and Physiology 49 (11): 1221\u20131231.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"2139_CR90","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00726-011-0994-z","volume":"42","author":"S Condello","year":"2012","unstructured":"Condello, S., et al. 2012. Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson\u2019s disease. Amino Acids 42: 775\u2013781.","journal-title":"Amino Acids"},{"issue":"7","key":"2139_CR91","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1074\/jbc.M110.178905","volume":"286","author":"HY Qureshi","year":"2011","unstructured":"Qureshi, Hamid Y., and Hemant K. Paudel. 2011. Parkinsonian neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP) and \u03b1-synuclein mutations promote tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. Journal of Biological Chemistry 286 (7): 5055\u20135068.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"2139_CR92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neures.2007.06.1472","volume":"59","author":"E Suzuki","year":"2007","unstructured":"Suzuki, E., and T. Okada. 2007. Regional differences in GABAergic modulation for TEA-induced synaptic plasticity in rat hippocampal CA1, CA3 and dentate gyrus. Neuroscience Research 59 (2): 183\u2013190.","journal-title":"Neuroscience Research"},{"key":"2139_CR93","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1007\/s12035-016-0147-1","volume":"54","author":"MP Cunha","year":"2017","unstructured":"Cunha, M.P., et al. 2017. MPP+-lesioned mice: an experimental model of motor, emotional, memory\/learning, and striatal neurochemical dysfunctions. Molecular Neurobiology 54:6356\u20136377.","journal-title":"Molecular Neurobiology"},{"key":"2139_CR94","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","volume":"28","author":"M Moretti","year":"2015","unstructured":"Moretti, M., et al. 2015. Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-Methyl-4-phenylpyridinium (MPP+). Neurotoxicity research 28: 222\u2013231.","journal-title":"Neurotoxicity research"},{"issue":"3","key":"2139_CR95","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1139\/bcb-2019-0117","volume":"98","author":"M Mehrabani","year":"2020","unstructured":"Mehrabani, M., et al. 2020. Protective effect of hydralazine on a cellular model of Parkinson\u2019s disease: a possible role of hypoxia-inducible factor (HIF)-1\u03b1. Biochemistry and Cell Biology 98 (3): 405\u2013414.","journal-title":"Biochemistry and Cell Biology"},{"key":"2139_CR96","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00726-011-0994-z","volume":"42","author":"S Condello","year":"2012","unstructured":"Condello, S., et al. 2012. Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson\u2019s disease. Amino Acids 42: 775\u2013781.","journal-title":"Amino Acids"},{"issue":"1","key":"2139_CR97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.07085.x","volume":"116","author":"S Condello","year":"2011","unstructured":"Condello, S., et al. 2011. Agmatine effects on mitochondrial membrane potential andNF-\u03baB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. Journal of Neurochemistry 116 (1): 67\u201375.","journal-title":"Journal of Neurochemistry"},{"key":"2139_CR98","doi-asserted-by":"crossref","unstructured":"Xu, L. and J. Pu. 2016. Alpha-synuclein in Parkinson\u2019s disease: from pathogenetic dysfunction to potential clinical application. Parkinsons Dis. 2016: 1720621. https:\/\/pubmed.ncbi.nlm.nih.gov\/27610264","DOI":"10.1155\/2016\/1720621"},{"issue":"5","key":"2139_CR99","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/nu10050642","volume":"10","author":"M Kujawska","year":"2018","unstructured":"Kujawska, M., and J. Jodynis-Liebert. 2018. Polyphenols in Parkinson\u2019s disease: A systematic review of in vivo studies. Nutrients 10 (5): 642.","journal-title":"Nutrients"},{"issue":"8","key":"2139_CR100","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung, H.-C., et al. 2021. Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9 (8): 918.","journal-title":"Biomedicines"},{"issue":"14","key":"2139_CR101","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","volume":"28","author":"RA Arias-S\u00e1nchez","year":"2023","unstructured":"Arias-S\u00e1nchez, R.A., L. Torner, and B. Fenton Navarro. 2023. Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection. Molecules 28 (14): 5415.","journal-title":"Molecules"},{"issue":"24","key":"2139_CR102","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.3390\/nu14245373","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., et al. 2022. The interaction of polyphenols and the gut microbiota in neurodegenerative diseases. Nutrients 14 (24): 5373.","journal-title":"Nutrients"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02139-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:04:57Z","timestamp":1751969097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02139-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2139"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02139-7","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent from Patients"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}